A Characterization of the expression of 14-3-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis

14-3-3 is a highly conserved protein involved in a number of cellular processes including cell signalling, cell cycle regulation and gene transcription. Seven isoforms of the protein have been identified; β, γ, ε, ζ η σ and τ. The expression profile of the various isoforms in skin diseases is unknown. To investigate the expression of the seven 14-3-3 isoforms in involved and uninvolved skin from psoriasis, basal cell carcinoma (BCC), atopic dermatitis and nickel induced allergic contact dermatitis. Punch biopsies from involved and uninvolved skin were analyzed with quantitative reverse transcription-polymerase chain reaction to determine the mRNA expression of the 14-3-3 isoforms. The protein level of 14-3-3 isoforms was measured by Western blot technique in keratome biopsies from patients with psoriasis. Evaluation of dermal and epidermal protein expression was performed by immunofluorescence staining. Increased 14-3-3τ mRNA levels were detected in involved skin from patients with psoriasis, contact dermatitis and BCC. 14-3-3σ mRNA expression was increased in psoriasis and contact dermatitis, but not in BCC. In atopic dermatitis no significant difference between involved and uninvolved skin was found. The expression of the 14-3-3 isoforms was also studied at the protein level in psoriasis. Only 14-3-3τ expression was significantly increased in involved psoriatic skin compared with uninvolved skin. Immunofluorescence staining with 14-3-3τ- and 14-3-3σ-specific antibodies showed localization of both isoforms to the cytoplasm of the keratinocytes in the various skin sections. These results demonstrate a disease specific expression profile of the 14-3-3τ and 14-3-3σ iso-forms.

[1]  A. Aitken,et al.  Identification of different isoforms of 14-3-3 protein family in human dermal and epidermal layers , 2008, Molecular and Cellular Biochemistry.

[2]  Dihua Yu,et al.  14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling. , 2008, Cancer research.

[3]  Jesse D. Martinez,et al.  Overexpression of 14‐3‐3γ causes polyploidization in H322 lung cancer cells , 2007 .

[4]  Jesse D. Martinez,et al.  Overexpression of 14-3-3gamma causes polyploidization in H322 lung cancer cells. , 2007, Molecular carcinogenesis.

[5]  Anthony J. Muslin,et al.  The 14-3-3τ Phosphoserine-Binding Protein Is Required for Cardiomyocyte Survival , 2006, Molecular and Cellular Biology.

[6]  Anthony J. Muslin,et al.  Differential role of 14‐3‐3 family members in Xenopus development , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[7]  A. Aitken.  14-3-3 proteins: a historic overview. , 2006, Seminars in cancer biology.

[8]  M. Madsen,et al.  Protein Expression of TNF-α in Psoriatic Skin Is Regulated at a Posttranscriptional Level by MAPK-Activated Protein Kinase 21 , 2006, The Journal of Immunology.

[9]  N. Ahlborg,et al.  Nickel Elicits Concomitant and Correlated in vitro Production of Th1‐, Th2‐Type and Regulatory Cytokines in Subjects with Contact Allergy to Nickel , 2005, Scandinavian journal of immunology.

[10]  D. Bridges,et al.  14-3-3 Proteins: A Number of Functions for a Numbered Protein , 2005, Science's STKE.

[11]  D. Lodygin,et al.  The role of epigenetic inactivation of 14-3-3σ in human cancer , 2005, Cell Research.

[12]  J. Chung,et al.  Increased expression of 14-3-3varepsilon protein in intrinsically aged and photoaged human skin in vivo. , 2005, Mechanisms of Ageing and Development.

[13]  D. Lodygin,et al.  The role of epigenetic inactivation of 14-3-3sigma in human cancer. , 2005, Cell research.

[14]  D. Campbell,et al.  14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. , 2004, The Biochemical journal.

[15]  P. Anderson,et al.  MK2‐induced tristetraprolin:14‐3‐3 complexes prevent stress granule association and ARE‐mRNA decay , 2004, The EMBO journal.

[16]  J. Shabanowitz,et al.  MAPKAP Kinase 2 Phosphorylates Tristetraprolin on in Vivo Sites Including Ser178, a Site Required for 14-3-3 Binding* , 2004, Journal of Biological Chemistry.

[17]  K. Kragballe,et al.  Increased aggregation and arachidonic acid transformation by psoriatic platelets: evidence that platelet-derived 12-hydroxy-eicosatetraenoic acid increases keratinocyte DNA synthesis in vitro , 2004, Archives of Dermatological Research.

[18]  H. Hermeking.  The 14-3-3 cancer connection , 2003, Nature Reviews Cancer.

[19]  H. Hermeking,et al.  Analysis of 14-3-3σ expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma , 2003, Oncogene.

[20]  Bruce Tidor,et al.  Proteomic Identification of 14-3-3ζ as a Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Substrate: Role in Dimer Formation and Ligand Binding , 2003, Molecular and Cellular Biology.

[21]  M. V. van Hemert,et al.  14‐3‐3 proteins: key regulators of cell division, signalling and apoptosis , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[22]  Y. Takihara,et al.  Role of the β isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation , 2000 .

[23]  M. Hande,et al.  Inactivation of 14-3-3ς Influences Telomere Behavior and Ionizing Radiation-Induced Chromosomal Instability , 2000, Molecular and Cellular Biology.

[24]  T. Pandita,et al.  High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  K. Kinzler,et al.  14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression , 1997 .

[26]  K. Kinzler,et al.  14-3-3sigma is a p53-regulated inhibitor of G2/M progression. , 1997, Molecular cell.

[27]  M. Krečmerová,et al.  Lipases as Tools in the Synthesis of Prodrugs from Racemic 9-(2,3-Dihydroxypropyl)adenine , 2012, Molecules.

[28]  G. Martens,et al.  Evolutionary conservation of the 14-3-3 protein. , 1992, Biochemical and biophysical research communications.

[29]  K. Araki,et al.  Molecular cloning of cDNA coding for brain-specific 14-3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Boston,et al.  Human 14‐3‐3 Protein: Radioimmunoassay, Tissue Distribution, and Cerebrospinal Fluid Levels in Patients with Neurological Disorders , 1982, Journal of neurochemistry.

[31]  Sandra Lloyd Lesser.  Marine Biological Laboratory Woods Hole, Mass , 1954 .